60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.860
-0.010 (-0.53%)
At close: Apr 2, 2026, 4:00 PM EDT
1.750
-0.110 (-5.91%)
After-hours: Apr 2, 2026, 6:50 PM EDT
SXTP Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$469,698
Profits / Employee
-$2,455,053
Market Cap
2.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| Jaguar Health | 49 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 28 |
| Ensysce Biosciences | 8 |
| Adial Pharmaceuticals | 5 |
| Oragenics | 3 |
| Propanc Biopharma | 2 |
SXTP News
- 2 days ago - 60 Degrees Pharmaceuticals Announces 2025 Annual Results - GlobeNewsWire
- 15 days ago - 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - GlobeNewsWire
- 20 days ago - What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
- 22 days ago - 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial - GlobeNewsWire
- 2 months ago - 60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership - GlobeNewsWire
- 2 months ago - 60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - GlobeNewsWire
- 4 months ago - 60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026 - GlobeNewsWire